Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

TSX:BNS
TSX:BNSBanks

Scotiabank Q2 2026 Net Margin Strength Supports Bullish Narratives On Earnings Resilience

Bank of Nova Scotia (TSX:BNS) has put up solid headline figures for Q2 2026, with revenue of C$8.6b and basic EPS of C$2.01 alongside net income of C$2.5b. Over the last twelve months, revenue sits at C$32.8b with basic EPS of C$7.29 and net income of C$9.0b. In recent quarters, the bank has reported revenue of C$9.0b and EPS of C$1.48 in Q2 2025, C$7.3b and EPS of C$1.70 in Q4 2025, and C$8.5b and EPS of C$1.74 in Q1 2026. This latest print fits into a steady earnings run, with margins...
NYSE:CNK
NYSE:CNKEntertainment

Helix Exit From Cinemark Raises Questions On Institutional Sentiment And Value

Helix Partners Management LP has fully exited its stake in Cinemark Holdings (NYSE:CNK), according to recent SEC filings. The move removes one institutional investor from Cinemark’s shareholder base and may influence how some investors view the stock. Cinemark operates movie theatres, giving it direct exposure to box office trends, content release schedules, and changing consumer habits. The exit by Helix comes at a time when the theatre industry continues to adjust to streaming...
NYSE:NEXA
NYSE:NEXAMetals and Mining

Nexa Resources Governance Vote Could Reshape Shareholder Powers And Project Decisions

Nexa Resources (NYSE:NEXA) has proposed amendments to its Articles of Association. Shareholders are scheduled to vote on the changes at the 2026 Annual General Meeting and Extraordinary General Meeting on June 25, 2026. The proposed amendments relate to core governance rules that can affect shareholder rights and future corporate decisions. Nexa Resources, trading at $14.51, has seen its share price rise 65.1% year to date and 196.9% over the past year, with a 194.5% return over three...
NasdaqGS:GLUE
NasdaqGS:GLUEBiotechs

Does Early MRT-2359 Data And Insider Selling Shift The Bull Case For Monte Rosa (GLUE)?

In May 2026, Monte Rosa Therapeutics reported encouraging Phase 1/2 data for MRT-2359 in metastatic castration-resistant prostate cancer and shared new preclinical findings for MRT-55811 showing tumor regression across several cancer models. At the same time, director Anthony M. Manning exercised options and sold US$180,100 of stock, a routine move that contrasts with the company’s recent scientific progress. Next, we’ll examine how these early-stage oncology results, especially the...
LSE:MER
LSE:MERCommercial Services

European Undervalued Small Caps With Insider Buying To Watch In May 2026

As European markets experience a positive momentum, with the STOXX Europe 600 Index rising by 3.00% amid hopes for geopolitical de-escalation, investors are keenly observing small-cap stocks which may offer unique opportunities in this dynamic environment. With insider buying often seen as a signal of confidence in a company's potential, identifying undervalued small caps could be particularly appealing to those looking to navigate the current economic landscape marked by revised growth...
NYSE:BOX
NYSE:BOXSoftware

Box Q1 2027 Margin Compression Challenges Bullish Profitability Narratives

Box (BOX) opened Q1 2027 with total revenue of US$305.9 million and basic EPS of US$0.09 on net income of US$11.9 million, setting a measured tone for the new fiscal year. Over the past five reported quarters, revenue has moved from US$276.3 million in Q1 2026 to US$305.9 million in Q1 2027, while basic EPS has ranged from US$0.02 to US$0.48, giving investors a clear view of how the top line and per share earnings have tracked through recent periods. With trailing net profit margins below...
NYSE:OOMA
NYSE:OOMASoftware

Ooma (OOMA) Profitability Turnaround Reinforces Bullish Earnings Growth Narrative

Ooma (OOMA) has kicked off Q1 2027 with revenue of about US$81.1 million and basic EPS of roughly US$0.09, alongside net income of around US$2.6 million. This sets a clear earnings tone for the new fiscal year. The company has seen quarterly revenue move from about US$65.0 million and a small net loss in Q1 2026 to roughly US$81.1 million and a net profit of around US$2.6 million in Q1 2027. Trailing twelve month EPS sits at about US$0.33 on revenue of roughly US$289.7 million, so the latest...
NasdaqGS:API
NasdaqGS:APISoftware

Agora (API) Q1 Profit Holds But Step Down From Q4 Tests Bullish Margin Story

Agora (API) has reported Q1 2026 revenue of US$37.7 million and net income of US$1.1 million, equal to basic EPS of US$0.01, which follows a year where trailing twelve month revenue reached US$145.5 million and EPS came in at US$0.11. Over recent quarters the company has seen revenue move from US$33.3 million in Q1 2025 to US$38.2 million in Q4 2025 and EPS shift from US$0.00 to US$0.05 over the same period, providing a clearer view of how both top line and per share profitability have been...
OB:KIT
OB:KITElectronic

High Growth Tech Stocks in Europe for May 2026

As the European market experiences a positive shift with the STOXX Europe 600 Index rising by 3.00%, driven by optimism around geopolitical tensions easing in the Middle East, investors are keenly observing high-growth opportunities within the tech sector. In this environment, identifying promising tech stocks involves looking for companies that not only demonstrate innovative capabilities but also have strong adaptability to economic changes and inflation pressures, which are crucial given...
NasdaqCM:QTTB
NasdaqCM:QTTBBiotechs

Q32 Bio (QTTB) Is Up 126.6% After US$55M Private Placement With Top Healthcare Funds - Has The Bull Case Changed?

Q32 Bio Inc. recently entered into a securities purchase agreement to raise US$55,000,000 through a private placement of 6,725,000 common shares at US$8.00 each and pre-funded warrants for 150,000 shares at US$7.9999, with closing expected on May 28, 2026, subject to customary conditions. The round is led by BVF Partners L.P. with participation from RA Capital Management, OrbiMed, and Atlas Venture, highlighting strong institutional interest in funding Q32 Bio’s development plans. Next,...
NasdaqGS:PONY
NasdaqGS:PONYSoftware

Evaluating Pony AI (PONY) After A Recent Share Price Rebound And Conflicting Valuation Signals

Recent performance and business snapshot Pony AI (PONY) has drawn investor attention after a period where the stock rose 4.3% over the past day and 11.4% over the past week, while declining over the month and past 3 months. At a last close of US$9.74 and a market cap of about US$4.0b, the company is generating revenue of US$110.27m while reporting a net loss of US$141.39m. Reported annual revenue growth of 43.7% sits alongside net income growth of 25.7%. This helps frame how this autonomous...
BIT:REC
BIT:RECPharmaceuticals

3 European Stocks That May Be Undervalued In May 2026

As European markets experience gains, buoyed by hopes of de-escalation in the Middle East, the economic landscape remains challenging with revised growth forecasts and rising inflation concerns. In this environment, identifying undervalued stocks can be crucial for investors looking to capitalize on potential market inefficiencies and long-term value opportunities.
OM:MILDEF
OM:MILDEFAerospace & Defense

European Growth Stocks With Insider Ownership Up To 22%

As European markets experience a positive shift, driven by hopes of geopolitical de-escalation and rising indices such as Germany's DAX and France's CAC 40, investors are increasingly focusing on growth companies with substantial insider ownership. In the current environment marked by economic uncertainties and inflationary pressures, stocks with high insider ownership can be appealing due to the potential alignment of interests between company executives and shareholders.
NYSEAM:ELLO
NYSEAM:ELLORenewable Energy

Ellomay Capital Q1 Loss Worsening Challenges Bullish Narratives Around Premium P/S Valuation

Ellomay Capital (NYSEAM:ELLO) opened 2026 with Q1 revenue of €8.7 million and a loss of €10.7 million in net income, which translated into basic EPS of a €0.78 loss, while trailing 12 month revenue stood at €42.6 million with a €19.7 million net loss and a basic EPS loss of €1.46. Over recent quarters, revenue has moved within a relatively tight band from €8.7 million to €11.3 million, while quarterly EPS has swung between a €0.85 loss and a €0.53 profit, underscoring how earnings are still...
NYSE:DRI
NYSE:DRIHospitality

Did Darden’s (DRI) Beef-Driven Pricing Power Just Reframe Its Margin-Focused Investment Narrative?

Darden Restaurants recently reported past fiscal 2026 second-quarter results that were mixed, with earnings per share slightly beating expectations despite softer comparable sales and beef-driven cost inflation. The update underscored how Darden has been relying on pricing power, particularly in its higher-income steakhouse concepts, to help protect margins even as its longer-term revenue growth and gross margins remain relatively modest. We’ll now explore how this recent display of pricing...
NYSE:SQM
NYSE:SQMChemicals

SQM (NYSE:SQM) Q1 EPS Surge Tests Long Term Earnings Skepticism

Sociedad Química y Minera de Chile (NYSE:SQM) opened 2026 with Q1 revenue of about US$1.8 billion and basic EPS of US$1.28, setting a clear marker for how the year is starting. Over recent quarters, the company has seen revenue move from US$1,073.8 million in Q4 2024 to US$1,036.6 million in Q1 2025, then to US$1,760.0 million in Q1 2026. Over the same period, quarterly basic EPS shifted from US$0.42 to US$0.48 and then to US$1.28, giving investors a concrete view of how the top and bottom...
ENXTPA:ARAMI
ENXTPA:ARAMISpecialty Retail

European Penny Stocks To Watch In May 2026

The European stock markets have experienced a positive week, with the pan-European STOXX Europe 600 Index climbing by 3.00% amid hopes for de-escalation in the Middle East. This backdrop of cautious optimism presents an intriguing opportunity for investors to explore lesser-known segments of the market, such as penny stocks. While traditionally associated with smaller or newer companies, penny stocks can offer unique growth potential at lower price points when supported by strong financials...
ENXTPA:MLPLC
ENXTPA:MLPLCBuilding

Officina Stellare Leads These 3 Undiscovered Gems in Europe

As European markets experience a positive shift, with the STOXX Europe 600 Index rising by 3.00% amid hopes of geopolitical de-escalation, investors are increasingly looking towards small-cap companies as potential opportunities despite the EU's reduced growth forecasts. In this environment, identifying stocks that demonstrate resilience and innovation becomes crucial, particularly those that can navigate economic uncertainties while capitalizing on niche market strengths.
ENXTPA:ITP
ENXTPA:ITPPersonal Products

3 European Dividend Stocks Yielding Up To 6.4%

As European markets experience a positive upswing, with the STOXX Europe 600 Index rising by 3.00%, investors are navigating through a landscape shaped by geopolitical events and economic forecasts, including revised growth expectations from the European Commission. Amidst these dynamics, dividend stocks continue to attract attention for their potential to provide steady income streams in uncertain times.